CHRU de Strasbourg — Strasbourg

Public research footprint of CHRU de Strasbourg, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Nodal Marginal Zone Lymphoma · Relapsing-remitting Multiple Sclerosis · Myelodysplastic Neoplasms

Recently updated registry entries

NCT07085377 — Autonomous Methadone Delivery System by Nurses (Recruiting)
NCT03466411 — A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to… (Active Not Recruiting)
NCT06741969 — Nipocalimab in Moderate to Severe Sjogren's Disease (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHRU de Strasbourg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.